Thurston, Springer, Miller, Herd & Titak, Inc. Novo Cure LTD Call Options Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $558 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVCR
# of Institutions
293Shares Held
75.8MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$201 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$195 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$147 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$79.7 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$45.3 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.74B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...